5-MeO-DMT

Complex slow waves in the human brain under 5-MeO-DMT

This naturalistic EEG study (n=29) examines the effects of inhaled synthetic 5-MeO-DMT (12mg) on brain activity in healthy individuals. It finds that 5-MeO-DMT radically reorganises low-frequency neural activity flows, making them incoherent, heterogeneous, and nonrecurring. It also causes broadband activity to exhibit slower, more stable, low-dimensional behaviour with increased energy barriers to rapid global shifts.

Authors

  • Blackburne, G.
  • Fabus, M.
  • Kamboj, S. K.

Published

Cell Reports
individual Study

Abstract

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic drug known for its uniquely profound effects on consciousness; however, it remains unknown how it affects the brain. We collected electroencephalography (EEG) data of 29 healthy individuals before and after inhaling a high dose (12-mg) of vaporized synthetic 5-MeO-DMT. We replicate results from rodents showing amplified low-frequency oscillations but extend these findings by characterizing the complex organization of spatiotemporal fields of neural activity. We find that 5-MeO-DMT radically reorganizes low-frequency flows, causing them to become heterogeneous, viscous, and nonrecurring and to cease their travel forward and backward across the cortex. Further, we find a consequence of this reorganization in broadband activity, which exhibits more stable low-dimensional behavior with increased energy barriers for rapid global shifts. These findings provide a detailed empirical account of how 5-MeO-DMT sculpts human brain dynamics, revealing a set of atypical cortical slow-wave behaviors with significant implications for neuroscientific models of serotonergic psychedelics.

Unlocked with Blossom Pro

Research Summary of 'Complex slow waves in the human brain under 5-MeO-DMT'

Introduction

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is among the most potent and rapidly acting psychedelic compounds known, with a history of ritual use dating back over 1,000 years and increasing involvement in contemporary clinical trials for depression, bipolar disorder, and alcohol use disorder. Its subjective effects — characterised by a radical dissolution of the axes of time, space, and selfhood — are qualitatively distinct from those of DMT or psilocybin, which typically involve richly structured geometric visual experiences. At the peak of the 5-MeO-DMT experience, users report entering an ineffable state in which even the awareness of being a subject is suspended, suggesting a global deconstruction rather than reduction of consciousness. Despite this phenomenological distinctiveness and growing clinical relevance, 5-MeO-DMT had not been studied using human neuroscience methods at the time of this investigation. The researchers aimed to characterise the electroencephalographic (EEG) signatures of the acute 5-MeO-DMT brain state, with particular interest in distinguishing it from states of unconsciousness and examining how spatiotemporal neural dynamics relate to the compound's unique subjective effects.

Methods

EEG data were recorded from 64 channels in participants before and after inhaled 5-MeO-DMT (n = 19); 10 participants were excluded due to movement artefacts, yielding n = 13 for peak-window analyses (1.5-2.5 minutes post-inhalation). To avoid the limitations of conventional Fourier-based spectral methods — which assume stationarity and sinusoidality — the researchers applied empirical mode decomposition (EMD) and the Hilbert-Huang transform (HHT) to extract intrinsic oscillatory modes across 0.5-50 Hz. Results were corroborated using multitaper fast Fourier transform. Spatiotemporal wave propagation was characterised by interpolating instantaneous amplitude and phase onto a uniform scalp grid and computing velocity fields using fluid-dynamics mathematics. Global and local phase synchrony (coherence) and metastability were quantified using a Kuramoto-like formalism across a range of spatial radii. Broadband neural stability was assessed using four complementary measures: the decay time of the auto-mutual information function (intrinsic timescale), the maximum Lyapunov exponent (sensitivity to initial conditions), PCA eigenvalue analysis (dimensionality), and mean-squared displacement (MSD) energy landscape analysis. Subjective experience was assessed using 25 custom visual analog scale items, with dominance regression used to identify the strongest neural predictors of self-report scores.

Results

5-MeO-DMT produced rapid increases in both slow (<1.5 Hz) and fast (>20 Hz) oscillatory power, emerging within 20 seconds of inhalation and decaying after 8-10 minutes. The lowest-frequency bin (0.5 Hz) increased by 415% relative to baseline at the peak of the drug effect. Spectral distance analyses confirmed that the 5-MeO-DMT state maintained a distinct and consistent profile for approximately the first four minutes. Spatiotemporal analyses revealed that 5-MeO-DMT markedly reduced the phase synchrony (global coherence) and metastability of slow, delta, and ultra-slow wave modes (all p_FDR < 0.05), collapsing the topographic hierarchy of synchronisation across spatial scales. Rather than producing simple, coherent, globally propagating waves as seen in anaesthesia, 5-MeO-DMT generated complex, incoherent, and spatially fragmented wave patterns that failed to propagate through the cortical hierarchy. The intrinsic timescale of broadband activity doubled under 5-MeO-DMT (221.9 to 495.3 ms; p_FDR = 0.018), the maximum Lyapunov exponent decreased (p_FDR = 0.046), and variance explained by the first principal component increased (p_FDR = 0.027), together indicating that cortical dynamics became more stable and low-dimensional. Energy landscape analysis showed a significantly increased energetic cost for large global activity deviations (p_FDR = 0.001, d = 1.193). Ultra-slow wave field heterogeneity was the strongest neural predictor of subjective reports of ego dissolution (R² > 0.7 for top items including "body felt not my own" and "experienced sense of void").

Discussion

The results demonstrate that 5-MeO-DMT produces a neurodynamic state that is qualitatively distinct from both baseline consciousness and states of unconsciousness such as anaesthesia. The induction of complex, spatiotemporally disorganised, low-frequency wave patterns — rather than the simple coherent slow oscillations associated with loss of consciousness — challenges the view that diffuse high-amplitude slow activity is universally indicative of unconsciousness. The researchers propose that this pattern of wave disorganisation underlies the environmental disconnection characteristic of the 5-MeO-DMT experience, in which subjective experience becomes decoupled from sensory input without being eliminated. The shift towards more stable, low-dimensional broadband dynamics parallels the subjective quality of the state: a world stripped of the usual axes of variation. The researchers interpret this as consistent with enhanced parallel but poorly integrated information processing, speculating that local collision-based computation may be enhanced whilst global integration is diminished. This work underscores the limitations of univariate spectral measures — such as alpha power suppression — as universal markers of psychedelic effects, and advocates for comprehensive spatiotemporal frameworks capable of capturing the full diversity of human brain states. The relationship between ultra-slow wave heterogeneity and ego dissolution is highlighted as a promising neural correlate of altered self-referential processing.

Conclusion

This investigation presents the first detailed human neuroscientific study of 5-MeO-DMT, reporting novel disruptions in the spatiotemporal organisation of low-frequency cortical waves that underlie the compound's radically deconstructed state of consciousness. The findings emphasise the need for both a revised understanding of slow wave functions in subjective experience and more comprehensive spatiotemporal analytical methods in neuroscience to adequately characterise the full diversity of human brain states.

View full paper sections

METHODS

This study did not generate any new materials.

CONCLUSION

We demonstrate that 5-MeO-DMT, a short-acting psychedelic drug, produces a unique state in the human brain. This state is marked by amplified diffuse slow rhythmic activity that coalesces into spatiotemporally disorganized and dismantled wave patterns unable to travel up and down the putative cortical hierarchy. Furthermore, we find that this disruption pushes broadband neural activity toward a low-dimensional steady state, paralleling the subjective quality of the experience. Our results undermine the hypothesis that the induction of diffuse high-amplitude slow oscillations is a universal signature of loss of consciousness. They do, however, provide evidence that augmented low-frequency oscillations are related to environmental disconnection, where subjective experience becomes independent of sensory variables imported from the external world.This result therefore reinforces the need for establishing more robust neuroscientific methods for discriminating conscious states. We offer the theoretical and empirical contribution that a fruitful strategy will be found by moving beyond one-size-fits-all univariate metrics, such as oscillatory power, toward comprehensive frameworks that permit the detailed characterization of complex spatiotemporal activity structures. By tracking the extended spatiotemporal patterns of low-frequency flows of neural activity, we discovered crucial characteristics of the 5-MeO-DMT brain state that distinguish it from states of unconsciousness. Rather than triggering simple, coherent, fluid, persistent, recurrent propagating global waves like in anesthesia,we found that 5-MeO-DMT induces complex, incoherent, viscous, fleeting, unique wave patterns. While these diverse local flows constrain cortex-wide propagation, it may be the case that they enhance a form of regional collision-based distributed dynamical computation.The 5-MeO-DMT state may therefore be marked by enhanced parallel, but not necessarily integrated, information processing.Future work should investigate how spatiotemporal flow structures relate to taxonomies of multivariate information dynamics, including measures of information transfer and integration.We found that 5-MeO-DMT instigates more stable low-dimensional broadband behavior with a decreased likelihood of major rapid global activity reconfiguration. These results are consistent with work in mice showing that cortical dynamics become less chaotic under 5-MeO-DMT.This overall simplicity may reasonably occur as a consequence of, rather than in spite of, the complexity seen in low-frequency flows. The lack of collective spatiotemporal coordination of the low-frequency flow fields implies that cortical dynamics are sub-served by a more fragmented network architecture that hinders the recruitment of multiple regions to effectively orchestrate simultaneous large global amplitude deviations. In short, segregation across spatiotemporal scales occurs, deconstructing the brain's canonical functional organization. Our results contest a number of key concepts in the developing literature on the neuroscience of serotonergic psychedelic drugs. First, whole-brain suppression of alpha power is considered a central feature of the psychedelic state.However, we found that alpha oscillations are not robustly reduced across every part of the cortex, with no deflation in the average oscillatory peak and only right parietal-occipital electrodes reaching significance for reductions in power. Future studies should investigate how alterations in properties such as waveform shape and rhythmicity may be key. Second, psychedelics are thought to ''liberate'' the bottom-up flow of information via feedforward neural activity.In contrast, we found a striking reduction in the probability that low-frequency waves flow in the anterior direction as well as the posterior direction. However, we note that the equivalence between anterior-flowing waves and feedforward processing is overly simplistic. Finally, psychedelics are thought to reduce the curvature of the energy landscape constraining neural activity, allowing more facile activity shifts and higher-dimensional dynamics.Yet, we found that 5-MeO-DMT steepened the brain's energy landscape, increasing the barriers for major rapid activity shifts and diminishing the dimensionality of neural dynamics. Our results therefore suggest that 5-MeO-DMT has a unique effect on the human brain compared to other classic tryptamine psychedelics. It is often stated that the unique effects of 5-MeO-DMT, compared to other serotonergic psychedelics, can be accounted for privileged binding to 5-HT 1a over 5-HT 2a receptors.Such an explanation is appealing to the present study given that the G βγ subunit of 5-HT 1a can activate G-protein-coupled inwardly rectifying potassium channels, causing hyperpolarization,potentially contributing to low-frequency oscillations. It has been shown that HTR2A-knockout (KO) mice, when administered 5-MeO-DMT, exhibit augmented low-frequency oscillations in primary visual cortex that are blocked by a 5-HT 1a antagonist; however, in a more recent study with wild-type mice, co-administration of 5-MeO-DMT with a 5-HT 1a antagonist actually further increased slow-wave activity.Nonetheless, if one is committed to a story based on 5-HT 1a , one would need to explain why other psychedelic drugs, including tryptamines, such as diisopropyltryptamine (DiPT), and phenethylamines, such as mescaline, 3,4methylenedioxyamphetamine (MDA), or 3,4,5-trimethoxamphetamine (TMA), also exhibit such a preference in bindingwhile inducing experiences unlike 5-MeO-DMT at high doses. Crucial to this is the fact that binding constants are distinct and dissociable from signaling potency and efficacy, that is to say, between physical association at a receptor and the ability to initiate downstream effects. Recent work has shown that 5-MeO-DMT, like the classical psychedelic lysergic acid diethylamide (LSD), exhibits equipotency at 5-HT 1a and 5-HT 2a .Moreover, to take the logic from Dourron et al. of a 5-HT 1a /5-HT 2a ratio,but here in terms of efficacy at their canonical G-proteins, 5-MeO-DMT would be considered less favoring of 5-HT 1a over 5-HT 2a than DMT is (1.2 vs. 1.4).In sum, the unique neuropsychopharmacology of 5-MeO-DMT will resist an explanation that simply pits binding at 5-HT 1a against 5-HT 2a but may be found in a more advanced treatment of its functional selectivity and biasing of particular signaling cascades at each receptor. At the mesoscale, we speculate that our results may represent the consequences of a unique shift in the balance of distinct thalamocortical subsystems. The presence of diffuse high-amplitude slow rhythmic activity, reduced communication through coherence, and an approach toward a low-dimensional steady state suggest a reduction in diffuse coupling in the brain. Non-specifically projecting thalamic structures, such as the mediodorsal and centromedian nuclei, may be relieved of their canonical tonic firing patterns, orchestrating supragranular cortical dynamics and global synchronization patterns.Instead, cyclical bursting and quiescence of these nuclei may occur, potentially resulting in functional deafferentationand cortical activity to become dominated by the intrinsic slow non-stationary bistability prescribed the anatomy of local cortical circuits.However, as internal awareness and arousal are maintained, the level of overall thalamocortical resonance expected by wakefulness is likely maintained. Indeed, the presence of fleeting viscous and heterogeneous local flow hints that there could be markedly greater driving gain by structures with targeted projections, like the pulvinar and ventral lateral nucleus, disrupting local excitation-inhibitory balance and overwhelming wave pattern dynamics. We note that this general hypothesis is distinct from existing corticothalamic models of psychedelic action that posit that there is an indiscriminate reduction in thalamic gating.Limitations of the study The study suffers from a small number of participants. A substantial proportion of participants were excluded from the analysis, reflecting our stringent exclusion of potential motion artifacts, a common issue for human neuroimaging studies with psychedelic drugs. Despite this, it remains possible that subtle, unaccounted-for motion artifacts could have an influence on EEG recordings. The control condition is a resting-state baseline rather than a blinded placebo group, meaning that expectancy factors are uncontrolled. A standardized single high dose (12mg) was administered to each participant, and blood samples were not taken throughout, meaning that inter-individual differences in pharmacokinetics are likely present. Methodologically, our analyses assume the cortex to be a relatively sparse, flat surface and therefore do not account for the high spatial resolution and convoluted geometry inherent to the human brain. Subsequent studies should therefore investigate 5-MeO-DMT with high-density electrophysiological recordings, effective cortical surface modeling, and novel vector field methods for latent Riemannian manifolds. Lastly, the present work does not integrate neural measures with time-resolved phenomenological data. Accordingly, future work should combine neuroimaging with rigorous and dynamic measures of subjective experience, such that inferences about both can mutually constrain each other.

Study Details

  • Study Type
    individual
  • Population
    humans
  • Characteristics
    brain measuresopen labelobservational
  • Journal
  • Compound

Your Library